Prescription Drugs - Denmark

  • Denmark
  • In Denmark, the revenue in the Prescription Drugs market is forecasted to reach US$2.10bn in 2024.
  • It is expected to exhibit an annual growth rate (CAGR 2024-2028) of 3.39%, leading to a market volume of US$2.40bn by 2028.
  • When compared globally, United States is projected to generate the most revenue, amounting to US$358.90bn in 2024.
  • In terms of per capita, in Denmark, US$0.35k in revenue is generated per person in 2024.
  • Denmark's pharmaceutical market is characterized by a strong emphasis on research and development, with a focus on innovative and cutting-edge prescription drugs.

Key regions: France, Canada, United States, Australia, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Denmark has been experiencing significant growth in recent years. Customer preferences have shifted towards a greater reliance on pharmacies for their prescription drug needs. This trend can be attributed to several factors, including convenience, accessibility, and the rising prevalence of chronic diseases.

Customer preferences:
Customers in Denmark have shown a growing preference for obtaining prescription drugs from pharmacies. This can be attributed to the convenience and accessibility offered by these establishments. Pharmacies are often located in close proximity to residential areas, making it easier for customers to access their medications. Additionally, many pharmacies offer extended hours of operation, allowing individuals to pick up their prescriptions at a time that is convenient for them. Another factor driving customer preferences is the rising prevalence of chronic diseases in Denmark. As the population ages and lifestyles change, the incidence of chronic conditions such as diabetes, cardiovascular disease, and respiratory disorders has increased. This has led to a greater demand for prescription drugs to manage these conditions, and pharmacies have become a trusted source for obtaining these medications.

Trends in the market:
One of the key trends in the Prescription Drugs (Pharmacies) market in Denmark is the increasing use of online pharmacies. With the advancement of technology and the widespread use of the internet, many customers now prefer to order their prescription drugs online. This allows them to avoid the hassle of visiting a physical pharmacy and provides the convenience of having their medications delivered directly to their doorstep. Online pharmacies also offer a wider range of products and often provide competitive pricing, further attracting customers. Another trend in the market is the growing focus on personalized medicine. Advances in medical research and technology have enabled healthcare providers to tailor treatments to individual patients based on their genetic makeup and specific health conditions. This has led to an increase in the demand for specialized prescription drugs that are customized to meet the unique needs of each patient. Pharmacies play a crucial role in providing these personalized medications and ensuring that patients receive the right treatment.

Local special circumstances:
Denmark has a well-developed healthcare system that provides universal access to healthcare services, including prescription drugs. The government heavily regulates the pharmaceutical industry to ensure the safety and efficacy of medications. This has created a high level of trust among consumers, who rely on pharmacies to provide them with quality prescription drugs.

Underlying macroeconomic factors:
The Prescription Drugs (Pharmacies) market in Denmark is also influenced by macroeconomic factors. The country has a high standard of living and a strong economy, which allows individuals to afford prescription medications. Additionally, the government provides subsidies for certain prescription drugs, making them more affordable for patients. This has contributed to the growth of the market as more people are able to access and afford the medications they need. In conclusion, the Prescription Drugs (Pharmacies) market in Denmark is experiencing growth due to customer preferences for convenience and accessibility, as well as the rising prevalence of chronic diseases. The market is also influenced by trends such as the increasing use of online pharmacies and the focus on personalized medicine. Denmark's well-developed healthcare system and strong economy further support the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)